ES2125976T3 - Otros derivados de indol con accion antiviral. - Google Patents

Otros derivados de indol con accion antiviral.

Info

Publication number
ES2125976T3
ES2125976T3 ES93906709T ES93906709T ES2125976T3 ES 2125976 T3 ES2125976 T3 ES 2125976T3 ES 93906709 T ES93906709 T ES 93906709T ES 93906709 T ES93906709 T ES 93906709T ES 2125976 T3 ES2125976 T3 ES 2125976T3
Authority
ES
Spain
Prior art keywords
derivatives
pct
indol
antiviral action
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93906709T
Other languages
English (en)
Inventor
Martin John Slater
George Stuart Cockerill
Edward Littler
Clive Leonard Yeates
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929206056A external-priority patent/GB9206056D0/en
Priority claimed from GB929206810A external-priority patent/GB9206810D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2125976T3 publication Critical patent/ES2125976T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A CIERTOS DERIVADOS DEL INDOL, SALES, ESTERES Y DERIVADOS DE LOS MISMOS FUNCIONALES FISIOLOGICAMENTE , PARA SU USO EN TERAPIA MEDICA Y EN PARTICULAR PARA SU USO EN LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA PROFILASIS DE AL MENOS UNA INFECCION VIRICA.
ES93906709T 1992-03-20 1993-03-19 Otros derivados de indol con accion antiviral. Expired - Lifetime ES2125976T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929206056A GB9206056D0 (en) 1992-03-20 1992-03-20 Indole derivatives
GB929206810A GB9206810D0 (en) 1992-03-27 1992-03-27 Indole derivatives

Publications (1)

Publication Number Publication Date
ES2125976T3 true ES2125976T3 (es) 1999-03-16

Family

ID=26300559

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93906709T Expired - Lifetime ES2125976T3 (es) 1992-03-20 1993-03-19 Otros derivados de indol con accion antiviral.

Country Status (9)

Country Link
US (1) US5547976A (es)
EP (1) EP0630242B1 (es)
JP (1) JPH07504674A (es)
AT (1) ATE175873T1 (es)
AU (1) AU685389B2 (es)
CA (1) CA2130836A1 (es)
DE (1) DE69323183T2 (es)
ES (1) ES2125976T3 (es)
WO (1) WO1993018766A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
GB9319297D0 (en) * 1993-09-17 1993-11-03 Wellcome Found Indole derivatives
CA2144940A1 (en) * 1994-03-18 1995-09-19 Chikara Murakata Therapeutic agent for thrombocytopenia and indolocarbazole derivatives
GB9416467D0 (en) * 1994-08-13 1994-10-05 Wellcome Found Compounds for use in medicine
FR2725371B1 (fr) * 1994-10-05 1997-08-29 Techni Pharma Nouveau procede de fabrication de suppositoires
US5808060A (en) * 1995-12-11 1998-09-15 Cephalon, Inc. Fused isoindolones
US5932618A (en) * 1996-11-04 1999-08-03 Signal Pharmaceuticals, Inc. Anti-viral agents and methods relating to the use thereof
CA2267207C (en) 1997-08-04 2008-10-28 Tonen Corporation Methods for detecting or assaying virus
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
ES2189597B2 (es) * 2000-07-18 2004-06-16 Fundacion Universitaria San Pablo-Ceu Derivados de 12,13-dihidro-5h-indolo(2,3-a)pirrolo(3,4-c)carbazol-5,7(6h)-diona como agentes antineoplasicos.
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
DE10161940A1 (de) * 2001-12-17 2003-07-03 Nad Ag N-Carbacyclus-monosubstitutierte Indolocarbazole als Proteinkinase-inhibitoren
CA2563761C (en) * 2004-04-26 2009-12-29 Pfizer Inc. Inhibitors of the hiv integrase enzyme
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
ITMI20091432A1 (it) * 2009-08-06 2011-02-07 Isagro Ricerca Srl Derivati dell'n-idrossimaleimmide ad elevata attivita' fungicida e relativo uso
WO2015140792A1 (en) * 2014-03-16 2015-09-24 Hadasit Medical Research Services And Development Ltd. Type iii deiodinase inhibitors and uses thereof
EP3169337A1 (en) 2014-07-17 2017-05-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
CN106432250B (zh) * 2016-09-07 2018-07-10 河南师范大学 具有抗癌活性的吲哚[2,3-a]吡咯[3,4-c]咔唑-5,7-二酮-6-缩氨基硫脲类化合物及其制备方法和应用
CN106478643B (zh) * 2016-09-07 2018-07-10 河南师范大学 吲哚[2,3-a]吡咯[3,4-c]咔唑-5,7-二酮-6-芳腙类化合物及其制备方法和在抗癌药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) * 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4567143A (en) * 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
US4743594A (en) * 1984-09-17 1988-05-10 Schering Corporation Antibiotic, antitumor compounds and their use
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
DE3803620A1 (de) * 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE3835842A1 (de) * 1988-10-21 1990-04-26 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
JP3010675B2 (ja) * 1989-03-23 2000-02-21 萬有製薬株式会社 抗腫瘍性物質ｂｅ―１３７９３ｃ
US5496809A (en) * 1989-05-10 1996-03-05 Bristol-Myers Squibb Co Stable solutions of rebeccamycin analog
DE3924538A1 (de) * 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung
DE3935066A1 (de) * 1989-10-20 1991-04-25 Lohmann Rudolf Lomapharm Verfahren zur isolierung von violacein und seine verwendung zur prophylaxe und therapie von viruserkrankungen
WO1991009034A1 (en) * 1989-12-14 1991-06-27 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes subsp. copiosa subsp. nov. scc 1951 atcc 53856
DE3942296A1 (de) * 1989-12-21 1991-06-27 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them
EP0445736A1 (en) * 1990-03-06 1991-09-11 Bristol-Myers Squibb Company Rebeccamycin analog and pharmaceutical composition containing it
ATE158298T1 (de) * 1990-05-11 1997-10-15 Banyu Pharma Co Ltd Be-13793c-derivat mit antitumorwirkung

Also Published As

Publication number Publication date
ATE175873T1 (de) 1999-02-15
EP0630242B1 (en) 1999-01-20
AU3761493A (en) 1993-10-21
DE69323183T2 (de) 1999-05-27
WO1993018766A1 (en) 1993-09-30
AU685389B2 (en) 1998-01-22
JPH07504674A (ja) 1995-05-25
US5547976A (en) 1996-08-20
CA2130836A1 (en) 1993-09-30
EP0630242A1 (en) 1994-12-28
DE69323183D1 (de) 1999-03-04

Similar Documents

Publication Publication Date Title
ES2125976T3 (es) Otros derivados de indol con accion antiviral.
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
EA199901031A1 (ru) Производные бензимидазола
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
ATE185483T1 (de) Antivirale nucleosidkombination
DE69019533D1 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
DE69102704D1 (de) Orales, melatonin enthaltendes arzneimittel.
ES2132383T3 (es) Inhibidores de proteasa hiv.
DK0625158T3 (da) Terapeutiske nucleosider af 2',3'-dideoxy-3'-fluorpurinrækken
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
MC1930A1 (fr) Produit antiviral
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
UA37251C2 (uk) Лікарський засіб для лікування або профілактики вірусної інфекції гепатиту в і спосіб лікування вірусної інфекції гепатиту в
MY111746A (en) Therapeutic nucleosides.
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
MX9201288A (es) Metodo de tratamiento.
DE69323191T2 (de) Wasserlösliche retinoide
ES2078380T3 (es) Oligofosfatos de accion antiviral.
DE59208280D1 (de) Oligo-2'-desoxynukleotide und ihre verwendung als arzneimittel mit antiviraler wirksamkeit
CA2193665A1 (en) Benzimidazole derivatives for the treatment and prophylaxis of virus infections

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 630242

Country of ref document: ES